BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...
Addiction
Avenues Recovery Center to Open New 146-Bed Residential Addiction Treatment Facility in Baton Rouge
BATON ROUGE, LA / ACCESSWIRE / October 8, 2024 / Avenues Recovery Center is proud to announce the anticipated grand...
VitalHub Completes Acquisition of MedCurrent Corporation
TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (“VitalHub” or the “Company”) is pleased to...
Sunwave Health and High Watch Recovery Center/Alina Lodge Announce Strategic Partnership to Revolutionize Behavioral Health Care
DELRAY BEACH, Fla., Oct. 7, 2024 /PRNewswire/ -- Sunwave Health, a leading provider of healthcare software solutions, is proud to...
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
TAMPA, Fla., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of...
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million...
Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program
Toronto, Ontario--(Newsfile Corp. - October 4, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...
Sober Sidekick by Empathy Health Technologies secures $2.8 million in seed funding
BENTONVILLE, Ark., Oct. 3, 2024 /PRNewswire/ -- On a mission to create an epic wave of comeback stories and transform...
Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
-- New J-code issued by the Centers for Medicare and Medicaid Services expected to standardize and streamline billing and reimbursement...
ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth
LOS ANGELES, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and...
Ridge RTC Adolescent Residential Treatment Center Welcomes Dr. Charles Jin, Highly Accomplished Psychiatrist, to Team
MILTON, NH / ACCESSWIRE / October 2, 2024 / Ridge RTC Adolescent Residential Treatment Center is proud to announce the...
Recovery Springs Launches Initiative to Encourage Seeking Help for Addiction
Recovery Springs Takes a Bold Stand Against Addiction Stigma, Promoting Individuals to Overcome Barriers and Seek Help in a Judgment-Free...
The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding...
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
SEATTLE and VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...
Axis Integrated Mental Health Recognized as Top Startup for Advancing Collaborative Mental Health Care
Top Startup Award Marks a Year of Milestones for Colorado's Leading Mental Health InnovatorWESTMINSTER, CO / ACCESSWIRE / September 30,...
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
Company to leverage capital and Valor’s expertise for strategic initiatives building market awareness, R&D roadmap, data analysis capabilities, and expanding...
The Ultrasound Event 2025: Pioneering the Future of Medical Ultrasound
ORLANDO, Fla., Sept. 25, 2024 /PRNewswire/ -- The American Institute of Ultrasound in Medicine (AIUM) is excited to announce the...
Press Release for The Changing Face of Addiction VIRTUAL Summit
Join us for an enlightening and transformative experience at the Changing Face of Addiction Virtual Summit, where we bring together...
Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Topline results expected in fourth quarter of 2024GLEN ALLEN, Va., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:...
Awakn Life Sciences Announces Upsizing and Closing of Tranche of Private Placement Financing
Toronto, Ontario--(Newsfile Corp. - September 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...